
The Associated Press @AP
A long-awaited review of prescription opioids, including their risks and contribution to the U.S. overdose epidemic, is still underway at @US_FDA, officials said Tuesday. The news is unlikely to appease critics who say the FDA needs to take bolder action. https://t.co/di5yTa8bpv — PolitiTweet.org